Clinical trial · Observational
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
A Real-World Study Investigating Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
NCT03349762CI-TRIAL-00077658recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the efficacy and safety of Huaier granules for Prevention of Recurrence and Metastasis of colorectal cancer patients following radical surgery
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- Observational 1
- description
- Radiotherapy or Chemotherapy
- label
- Observational 2
- description
- Huaier Granule \& Radiotherapy or chemotherapy
- label
- Observational 3
- description
- Huaier Granules
Primary outcomes (4)
- measure
- Disease-Free Survival(DFS)
- timeFrame
- 36 months
- description
- Disease free survival (DFS) was defined as the time from participation to the time of tumor recurrence or death.
- measure
- Overall survival(OS)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Males or females ages 18-75 years; 2. The first time to the therapy of patients who received the radical surgery within two months, Postoperative histopathology confirms the diagnosis of colorectal cancer with stage IIB, IIC and III ( TNM classification) 3. ECOG score of 0-2; 4. No history of malignant tumors; 5. The patients are volunteered for the study, sign informed consent form and cooperate with Investigator to collect data. Exclusion Criteria: 1. Patients have basic diseases including heart diseases, cerebrovascular disease, lung disease, severe hypertension or diabetes with poor glycemic control; 2. confirmed infections after surgery ; 3. Patients who have post-surgery complications or who are currently under the influence of the radical surgery for colorectal cancer; 4. Being infected with syphilis or with other blood-borne infectious diseases; 5. Pregnancy or lactation; or women of childbearing potential not using contraception; 6. Patients who have taken Traditional Chinese Medicines with efficacy and indications similar to that of Huaier granule - including, but not limited to, compound Banmao capsule., Huachansu capsule, Kangai Injection and Pingxiao tablets; 7. Patients who are suffering from mental illness or Conditions that are considered not suitable for this study investigators.
References
Publications (0)
Data not yet available
No reference posted for this study.